nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Dapsone—malaria	0.381	1	CbGbCtD
Risedronate—FDPS—blood plasma—malaria	0.0243	0.166	CbGeAlD
Risedronate—FDPS—saliva-secreting gland—malaria	0.0141	0.0962	CbGeAlD
Risedronate—FDPS—hematopoietic system—malaria	0.0134	0.0918	CbGeAlD
Risedronate—FDPS—kidney—malaria	0.011	0.0752	CbGeAlD
Risedronate—PTGS2—endothelium—malaria	0.0105	0.0716	CbGeAlD
Risedronate—FDPS—digestive system—malaria	0.00933	0.0638	CbGeAlD
Risedronate—PTGS2—blood plasma—malaria	0.0093	0.0636	CbGeAlD
Risedronate—FDPS—blood—malaria	0.00889	0.0608	CbGeAlD
Risedronate—FDPS—bone marrow—malaria	0.0086	0.0588	CbGeAlD
Risedronate—FDPS—liver—malaria	0.00695	0.0475	CbGeAlD
Risedronate—FDPS—brain—malaria	0.00552	0.0377	CbGeAlD
Risedronate—PTGS2—hematopoietic system—malaria	0.00514	0.0352	CbGeAlD
Risedronate—PTGS2—kidney—malaria	0.00422	0.0288	CbGeAlD
Risedronate—PTGS2—digestive system—malaria	0.00358	0.0245	CbGeAlD
Risedronate—PTGS2—blood—malaria	0.00341	0.0233	CbGeAlD
Risedronate—PTGS2—bone marrow—malaria	0.0033	0.0225	CbGeAlD
Risedronate—PTGS2—liver—malaria	0.00266	0.0182	CbGeAlD
Risedronate—Abdominal pain upper—Quinine—malaria	0.0024	0.00509	CcSEcCtD
Risedronate—Abdominal pain upper—Quinidine—malaria	0.0024	0.00509	CcSEcCtD
Risedronate—Influenza—Dapsone—malaria	0.00239	0.00507	CcSEcCtD
Risedronate—Breast disorder—Quinidine—malaria	0.00238	0.00504	CcSEcCtD
Risedronate—Breast disorder—Quinine—malaria	0.00238	0.00504	CcSEcCtD
Risedronate—Abdominal distension—Clindamycin—malaria	0.00233	0.00494	CcSEcCtD
Risedronate—Tinnitus—Sulfadiazine—malaria	0.00232	0.00492	CcSEcCtD
Risedronate—Muscular weakness—Quinidine—malaria	0.00232	0.00491	CcSEcCtD
Risedronate—Muscular weakness—Quinine—malaria	0.00232	0.00491	CcSEcCtD
Risedronate—Gastrointestinal disorder—Proguanil—malaria	0.0023	0.00488	CcSEcCtD
Risedronate—Asthma—Quinidine—malaria	0.00227	0.00482	CcSEcCtD
Risedronate—Asthma—Quinine—malaria	0.00227	0.00482	CcSEcCtD
Risedronate—Abdominal discomfort—Clindamycin—malaria	0.00222	0.00471	CcSEcCtD
Risedronate—Angina pectoris—Quinidine—malaria	0.00221	0.00469	CcSEcCtD
Risedronate—Angina pectoris—Quinine—malaria	0.00221	0.00469	CcSEcCtD
Risedronate—Liver function test abnormal—Quinidine barbiturate—malaria	0.00219	0.00464	CcSEcCtD
Risedronate—Gastrointestinal pain—Proguanil—malaria	0.00218	0.00462	CcSEcCtD
Risedronate—Vomiting—Pyrimethamine—malaria	0.00217	0.00461	CcSEcCtD
Risedronate—Abdominal pain upper—Quinidine barbiturate—malaria	0.00217	0.00459	CcSEcCtD
Risedronate—Upper respiratory tract infection—Clindamycin—malaria	0.00215	0.00456	CcSEcCtD
Risedronate—Breast disorder—Quinidine barbiturate—malaria	0.00214	0.00454	CcSEcCtD
Risedronate—PTGS2—brain—malaria	0.00211	0.0145	CbGeAlD
Risedronate—Abdominal pain—Proguanil—malaria	0.00211	0.00446	CcSEcCtD
Risedronate—Body temperature increased—Proguanil—malaria	0.00211	0.00446	CcSEcCtD
Risedronate—Muscular weakness—Quinidine barbiturate—malaria	0.00209	0.00444	CcSEcCtD
Risedronate—Abdominal distension—Pentoxifylline—malaria	0.00206	0.00437	CcSEcCtD
Risedronate—Asthma—Quinidine barbiturate—malaria	0.00205	0.00435	CcSEcCtD
Risedronate—Urinary tract infection—Clindamycin—malaria	0.00201	0.00425	CcSEcCtD
Risedronate—Sinusitis—Dapsone—malaria	0.002	0.00425	CcSEcCtD
Risedronate—Angina pectoris—Quinidine barbiturate—malaria	0.002	0.00423	CcSEcCtD
Risedronate—Angina pectoris—Pentoxifylline—malaria	0.00199	0.00423	CcSEcCtD
Risedronate—Abdominal discomfort—Pentoxifylline—malaria	0.00196	0.00416	CcSEcCtD
Risedronate—Vertigo—Sulfadiazine—malaria	0.00195	0.00413	CcSEcCtD
Risedronate—Pharyngitis—Dapsone—malaria	0.0019	0.00403	CcSEcCtD
Risedronate—Arthralgia—Sulfadiazine—malaria	0.00184	0.00391	CcSEcCtD
Risedronate—Haemoglobin—Quinidine—malaria	0.00183	0.00387	CcSEcCtD
Risedronate—Haemoglobin—Quinine—malaria	0.00183	0.00387	CcSEcCtD
Risedronate—Infestation NOS—Pentoxifylline—malaria	0.00182	0.00387	CcSEcCtD
Risedronate—Infestation—Pentoxifylline—malaria	0.00182	0.00387	CcSEcCtD
Risedronate—Diarrhoea—Proguanil—malaria	0.00182	0.00386	CcSEcCtD
Risedronate—Haemorrhage—Quinidine—malaria	0.00182	0.00385	CcSEcCtD
Risedronate—Haemorrhage—Quinine—malaria	0.00182	0.00385	CcSEcCtD
Risedronate—Urinary tract disorder—Quinidine—malaria	0.0018	0.00381	CcSEcCtD
Risedronate—Urinary tract disorder—Quinine—malaria	0.0018	0.00381	CcSEcCtD
Risedronate—Tinnitus—Dapsone—malaria	0.00179	0.00379	CcSEcCtD
Risedronate—Urethral disorder—Quinidine—malaria	0.00178	0.00378	CcSEcCtD
Risedronate—Urethral disorder—Quinine—malaria	0.00178	0.00378	CcSEcCtD
Risedronate—Conjunctivitis—Pentoxifylline—malaria	0.00177	0.00376	CcSEcCtD
Risedronate—Hepatobiliary disease—Pentoxifylline—malaria	0.00173	0.00366	CcSEcCtD
Risedronate—Eye disorder—Quinine—malaria	0.0017	0.0036	CcSEcCtD
Risedronate—Eye disorder—Quinidine—malaria	0.0017	0.0036	CcSEcCtD
Risedronate—Tinnitus—Quinidine—malaria	0.0017	0.00359	CcSEcCtD
Risedronate—Tinnitus—Quinine—malaria	0.0017	0.00359	CcSEcCtD
Risedronate—Vomiting—Proguanil—malaria	0.00169	0.00359	CcSEcCtD
Risedronate—Cardiac disorder—Quinine—malaria	0.00169	0.00358	CcSEcCtD
Risedronate—Cardiac disorder—Quinidine—malaria	0.00169	0.00358	CcSEcCtD
Risedronate—Rash—Proguanil—malaria	0.00168	0.00356	CcSEcCtD
Risedronate—Dermatitis—Proguanil—malaria	0.00168	0.00356	CcSEcCtD
Risedronate—Headache—Proguanil—malaria	0.00167	0.00354	CcSEcCtD
Risedronate—Haemoglobin—Quinidine barbiturate—malaria	0.00165	0.0035	CcSEcCtD
Risedronate—Haemoglobin—Pentoxifylline—malaria	0.00165	0.00349	CcSEcCtD
Risedronate—Immune system disorder—Quinidine—malaria	0.00164	0.00348	CcSEcCtD
Risedronate—Immune system disorder—Quinine—malaria	0.00164	0.00348	CcSEcCtD
Risedronate—Haemorrhage—Quinidine barbiturate—malaria	0.00164	0.00348	CcSEcCtD
Risedronate—Mediastinal disorder—Quinine—malaria	0.00164	0.00347	CcSEcCtD
Risedronate—Mediastinal disorder—Quinidine—malaria	0.00164	0.00347	CcSEcCtD
Risedronate—Haemorrhage—Pentoxifylline—malaria	0.00164	0.00347	CcSEcCtD
Risedronate—Urinary tract disorder—Quinidine barbiturate—malaria	0.00162	0.00344	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00161	0.00342	CcSEcCtD
Risedronate—Urethral disorder—Quinidine barbiturate—malaria	0.00161	0.00341	CcSEcCtD
Risedronate—Insomnia—Sulfadiazine—malaria	0.0016	0.00339	CcSEcCtD
Risedronate—Mental disorder—Quinine—malaria	0.00159	0.00338	CcSEcCtD
Risedronate—Mental disorder—Quinidine—malaria	0.00159	0.00338	CcSEcCtD
Risedronate—Flatulence—Clindamycin—malaria	0.00159	0.00337	CcSEcCtD
Risedronate—Malnutrition—Quinidine—malaria	0.00158	0.00336	CcSEcCtD
Risedronate—Malnutrition—Quinine—malaria	0.00158	0.00336	CcSEcCtD
Risedronate—Nausea—Proguanil—malaria	0.00158	0.00335	CcSEcCtD
Risedronate—Back pain—Clindamycin—malaria	0.00156	0.00331	CcSEcCtD
Risedronate—Muscle spasms—Clindamycin—malaria	0.00155	0.00329	CcSEcCtD
Risedronate—Eye disorder—Quinidine barbiturate—malaria	0.00153	0.00325	CcSEcCtD
Risedronate—Tinnitus—Quinidine barbiturate—malaria	0.00153	0.00324	CcSEcCtD
Risedronate—Gastrointestinal disorder—Sulfadiazine—malaria	0.00153	0.00324	CcSEcCtD
Risedronate—Cardiac disorder—Quinidine barbiturate—malaria	0.00152	0.00323	CcSEcCtD
Risedronate—Vertigo—Dapsone—malaria	0.0015	0.00318	CcSEcCtD
Risedronate—Anaemia—Clindamycin—malaria	0.00149	0.00316	CcSEcCtD
Risedronate—Immune system disorder—Quinidine barbiturate—malaria	0.00148	0.00314	CcSEcCtD
Risedronate—Immune system disorder—Pentoxifylline—malaria	0.00148	0.00314	CcSEcCtD
Risedronate—Mediastinal disorder—Quinidine barbiturate—malaria	0.00148	0.00314	CcSEcCtD
Risedronate—Arrhythmia—Pentoxifylline—malaria	0.00146	0.0031	CcSEcCtD
Risedronate—Cough—Dapsone—malaria	0.00146	0.00309	CcSEcCtD
Risedronate—Vertigo—Clindamycin—malaria	0.00145	0.00307	CcSEcCtD
Risedronate—Angioedema—Quinine—malaria	0.00145	0.00307	CcSEcCtD
Risedronate—Angioedema—Quinidine—malaria	0.00145	0.00307	CcSEcCtD
Risedronate—Gastrointestinal pain—Sulfadiazine—malaria	0.00145	0.00307	CcSEcCtD
Risedronate—Mental disorder—Quinidine barbiturate—malaria	0.00144	0.00305	CcSEcCtD
Risedronate—Malnutrition—Quinidine barbiturate—malaria	0.00143	0.00303	CcSEcCtD
Risedronate—Vertigo—Quinidine—malaria	0.00142	0.00301	CcSEcCtD
Risedronate—Vertigo—Quinine—malaria	0.00142	0.00301	CcSEcCtD
Risedronate—Syncope—Quinidine—malaria	0.00142	0.00301	CcSEcCtD
Risedronate—Syncope—Quinine—malaria	0.00142	0.00301	CcSEcCtD
Risedronate—Flatulence—Pentoxifylline—malaria	0.00141	0.00298	CcSEcCtD
Risedronate—Urticaria—Sulfadiazine—malaria	0.0014	0.00298	CcSEcCtD
Risedronate—Abdominal pain—Sulfadiazine—malaria	0.0014	0.00296	CcSEcCtD
Risedronate—Body temperature increased—Sulfadiazine—malaria	0.0014	0.00296	CcSEcCtD
Risedronate—Hypertension—Clindamycin—malaria	0.00139	0.00295	CcSEcCtD
Risedronate—Loss of consciousness—Quinidine—malaria	0.00139	0.00295	CcSEcCtD
Risedronate—Loss of consciousness—Quinine—malaria	0.00139	0.00295	CcSEcCtD
Risedronate—Back pain—Pentoxifylline—malaria	0.00138	0.00292	CcSEcCtD
Risedronate—Muscle spasms—Pentoxifylline—malaria	0.00137	0.00291	CcSEcCtD
Risedronate—Chest pain—Quinidine—malaria	0.00135	0.00286	CcSEcCtD
Risedronate—Myalgia—Quinidine—malaria	0.00135	0.00286	CcSEcCtD
Risedronate—Chest pain—Quinine—malaria	0.00135	0.00286	CcSEcCtD
Risedronate—Myalgia—Quinine—malaria	0.00135	0.00286	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00134	0.00284	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00134	0.00284	CcSEcCtD
Risedronate—Anaemia—Pentoxifylline—malaria	0.00132	0.00279	CcSEcCtD
Risedronate—Angioedema—Quinidine barbiturate—malaria	0.00131	0.00277	CcSEcCtD
Risedronate—Angioedema—Pentoxifylline—malaria	0.0013	0.00276	CcSEcCtD
Risedronate—Hypersensitivity—Sulfadiazine—malaria	0.0013	0.00276	CcSEcCtD
Risedronate—Vertigo—Quinidine barbiturate—malaria	0.00128	0.00272	CcSEcCtD
Risedronate—Syncope—Quinidine barbiturate—malaria	0.00128	0.00272	CcSEcCtD
Risedronate—Shock—Quinidine—malaria	0.00127	0.00269	CcSEcCtD
Risedronate—Shock—Quinine—malaria	0.00127	0.00269	CcSEcCtD
Risedronate—Nervous system disorder—Quinidine—malaria	0.00127	0.00269	CcSEcCtD
Risedronate—Nervous system disorder—Quinine—malaria	0.00127	0.00269	CcSEcCtD
Risedronate—Loss of consciousness—Quinidine barbiturate—malaria	0.00126	0.00266	CcSEcCtD
Risedronate—Skin disorder—Quinine—malaria	0.00125	0.00266	CcSEcCtD
Risedronate—Skin disorder—Quinidine—malaria	0.00125	0.00266	CcSEcCtD
Risedronate—Pruritus—Sulfadiazine—malaria	0.00125	0.00265	CcSEcCtD
Risedronate—Insomnia—Dapsone—malaria	0.00123	0.00261	CcSEcCtD
Risedronate—Hypertension—Pentoxifylline—malaria	0.00123	0.00261	CcSEcCtD
Risedronate—Chest pain—Quinidine barbiturate—malaria	0.00122	0.00258	CcSEcCtD
Risedronate—Myalgia—Quinidine barbiturate—malaria	0.00122	0.00258	CcSEcCtD
Risedronate—Arthralgia—Quinidine barbiturate—malaria	0.00122	0.00258	CcSEcCtD
Risedronate—Myalgia—Pentoxifylline—malaria	0.00121	0.00257	CcSEcCtD
Risedronate—Chest pain—Pentoxifylline—malaria	0.00121	0.00257	CcSEcCtD
Risedronate—Anxiety—Quinidine barbiturate—malaria	0.00121	0.00257	CcSEcCtD
Risedronate—Diarrhoea—Sulfadiazine—malaria	0.00121	0.00256	CcSEcCtD
Risedronate—Anxiety—Pentoxifylline—malaria	0.00121	0.00256	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00121	0.00256	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00121	0.00256	CcSEcCtD
Risedronate—Dry mouth—Pentoxifylline—malaria	0.00119	0.00252	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Quinine—malaria	0.00118	0.0025	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Quinidine—malaria	0.00118	0.0025	CcSEcCtD
Risedronate—Dyspnoea—Clindamycin—malaria	0.00117	0.00249	CcSEcCtD
Risedronate—Dyspepsia—Clindamycin—malaria	0.00116	0.00246	CcSEcCtD
Risedronate—Infection—Pentoxifylline—malaria	0.00116	0.00245	CcSEcCtD
Risedronate—Dyspnoea—Quinidine—malaria	0.00115	0.00244	CcSEcCtD
Risedronate—Dyspnoea—Quinine—malaria	0.00115	0.00244	CcSEcCtD
Risedronate—Shock—Quinidine barbiturate—malaria	0.00115	0.00243	CcSEcCtD
Risedronate—Shock—Pentoxifylline—malaria	0.00114	0.00243	CcSEcCtD
Risedronate—Nervous system disorder—Quinidine barbiturate—malaria	0.00114	0.00242	CcSEcCtD
Risedronate—Gastrointestinal disorder—Clindamycin—malaria	0.00114	0.00241	CcSEcCtD
Risedronate—Fatigue—Clindamycin—malaria	0.00114	0.00241	CcSEcCtD
Risedronate—Skin disorder—Quinidine barbiturate—malaria	0.00113	0.0024	CcSEcCtD
Risedronate—Skin disorder—Pentoxifylline—malaria	0.00113	0.0024	CcSEcCtD
Risedronate—Constipation—Clindamycin—malaria	0.00113	0.00239	CcSEcCtD
Risedronate—Pain—Clindamycin—malaria	0.00113	0.00239	CcSEcCtD
Risedronate—Vomiting—Sulfadiazine—malaria	0.00112	0.00238	CcSEcCtD
Risedronate—Gastrointestinal disorder—Quinine—malaria	0.00112	0.00236	CcSEcCtD
Risedronate—Gastrointestinal disorder—Quinidine—malaria	0.00112	0.00236	CcSEcCtD
Risedronate—Rash—Sulfadiazine—malaria	0.00111	0.00236	CcSEcCtD
Risedronate—Dermatitis—Sulfadiazine—malaria	0.00111	0.00236	CcSEcCtD
Risedronate—Gastrointestinal pain—Dapsone—malaria	0.00111	0.00236	CcSEcCtD
Risedronate—Headache—Sulfadiazine—malaria	0.00111	0.00235	CcSEcCtD
Risedronate—Gastrointestinal pain—Clindamycin—malaria	0.00108	0.00228	CcSEcCtD
Risedronate—Body temperature increased—Dapsone—malaria	0.00108	0.00228	CcSEcCtD
Risedronate—Abdominal pain—Dapsone—malaria	0.00108	0.00228	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00106	0.00225	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00106	0.00225	CcSEcCtD
Risedronate—Gastrointestinal pain—Quinine—malaria	0.00106	0.00224	CcSEcCtD
Risedronate—Gastrointestinal pain—Quinidine—malaria	0.00106	0.00224	CcSEcCtD
Risedronate—Insomnia—Pentoxifylline—malaria	0.00105	0.00223	CcSEcCtD
Risedronate—Nausea—Sulfadiazine—malaria	0.00105	0.00223	CcSEcCtD
Risedronate—Urticaria—Clindamycin—malaria	0.00105	0.00222	CcSEcCtD
Risedronate—Abdominal pain—Clindamycin—malaria	0.00104	0.00221	CcSEcCtD
Risedronate—Body temperature increased—Clindamycin—malaria	0.00104	0.00221	CcSEcCtD
Risedronate—Dyspnoea—Quinidine barbiturate—malaria	0.00104	0.0022	CcSEcCtD
Risedronate—Dyspnoea—Pentoxifylline—malaria	0.00104	0.0022	CcSEcCtD
Risedronate—Urticaria—Quinine—malaria	0.00103	0.00218	CcSEcCtD
Risedronate—Urticaria—Quinidine—malaria	0.00103	0.00218	CcSEcCtD
Risedronate—Dyspepsia—Pentoxifylline—malaria	0.00102	0.00217	CcSEcCtD
Risedronate—Abdominal pain—Quinidine—malaria	0.00102	0.00216	CcSEcCtD
Risedronate—Body temperature increased—Quinidine—malaria	0.00102	0.00216	CcSEcCtD
Risedronate—Abdominal pain—Quinine—malaria	0.00102	0.00216	CcSEcCtD
Risedronate—Body temperature increased—Quinine—malaria	0.00102	0.00216	CcSEcCtD
Risedronate—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00101	0.00213	CcSEcCtD
Risedronate—Pain—Quinidine barbiturate—malaria	0.000997	0.00211	CcSEcCtD
Risedronate—Constipation—Quinidine barbiturate—malaria	0.000997	0.00211	CcSEcCtD
Risedronate—Constipation—Pentoxifylline—malaria	0.000995	0.00211	CcSEcCtD
Risedronate—Hypersensitivity—Clindamycin—malaria	0.00097	0.00206	CcSEcCtD
Risedronate—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000953	0.00202	CcSEcCtD
Risedronate—Hypersensitivity—Quinine—malaria	0.000952	0.00202	CcSEcCtD
Risedronate—Hypersensitivity—Quinidine—malaria	0.000952	0.00202	CcSEcCtD
Risedronate—Gastrointestinal pain—Pentoxifylline—malaria	0.000952	0.00202	CcSEcCtD
Risedronate—Asthenia—Clindamycin—malaria	0.000945	0.002	CcSEcCtD
Risedronate—Pruritus—Clindamycin—malaria	0.000932	0.00198	CcSEcCtD
Risedronate—Asthenia—Quinidine—malaria	0.000927	0.00196	CcSEcCtD
Risedronate—Asthenia—Quinine—malaria	0.000927	0.00196	CcSEcCtD
Risedronate—Urticaria—Quinidine barbiturate—malaria	0.000926	0.00196	CcSEcCtD
Risedronate—Urticaria—Pentoxifylline—malaria	0.000924	0.00196	CcSEcCtD
Risedronate—Abdominal pain—Quinidine barbiturate—malaria	0.000922	0.00195	CcSEcCtD
Risedronate—Body temperature increased—Quinidine barbiturate—malaria	0.000922	0.00195	CcSEcCtD
Risedronate—Body temperature increased—Pentoxifylline—malaria	0.00092	0.00195	CcSEcCtD
Risedronate—Abdominal pain—Pentoxifylline—malaria	0.00092	0.00195	CcSEcCtD
Risedronate—Pruritus—Quinidine—malaria	0.000914	0.00194	CcSEcCtD
Risedronate—Pruritus—Quinine—malaria	0.000914	0.00194	CcSEcCtD
Risedronate—Diarrhoea—Clindamycin—malaria	0.000901	0.00191	CcSEcCtD
Risedronate—Diarrhoea—Quinidine—malaria	0.000884	0.00187	CcSEcCtD
Risedronate—Diarrhoea—Quinine—malaria	0.000884	0.00187	CcSEcCtD
Risedronate—Dizziness—Clindamycin—malaria	0.000871	0.00185	CcSEcCtD
Risedronate—Vomiting—Dapsone—malaria	0.000866	0.00183	CcSEcCtD
Risedronate—Hypersensitivity—Quinidine barbiturate—malaria	0.000859	0.00182	CcSEcCtD
Risedronate—Hypersensitivity—Pentoxifylline—malaria	0.000857	0.00182	CcSEcCtD
Risedronate—Dizziness—Quinidine—malaria	0.000854	0.00181	CcSEcCtD
Risedronate—Dizziness—Quinine—malaria	0.000854	0.00181	CcSEcCtD
Risedronate—Headache—Dapsone—malaria	0.000853	0.00181	CcSEcCtD
Risedronate—Vomiting—Clindamycin—malaria	0.000837	0.00177	CcSEcCtD
Risedronate—Asthenia—Quinidine barbiturate—malaria	0.000836	0.00177	CcSEcCtD
Risedronate—Asthenia—Pentoxifylline—malaria	0.000835	0.00177	CcSEcCtD
Risedronate—Rash—Clindamycin—malaria	0.00083	0.00176	CcSEcCtD
Risedronate—Dermatitis—Clindamycin—malaria	0.000829	0.00176	CcSEcCtD
Risedronate—Headache—Clindamycin—malaria	0.000825	0.00175	CcSEcCtD
Risedronate—Pruritus—Quinidine barbiturate—malaria	0.000825	0.00175	CcSEcCtD
Risedronate—Pruritus—Pentoxifylline—malaria	0.000823	0.00175	CcSEcCtD
Risedronate—Vomiting—Quinidine—malaria	0.000821	0.00174	CcSEcCtD
Risedronate—Vomiting—Quinine—malaria	0.000821	0.00174	CcSEcCtD
Risedronate—Rash—Quinidine—malaria	0.000814	0.00173	CcSEcCtD
Risedronate—Rash—Quinine—malaria	0.000814	0.00173	CcSEcCtD
Risedronate—Dermatitis—Quinidine—malaria	0.000814	0.00173	CcSEcCtD
Risedronate—Dermatitis—Quinine—malaria	0.000814	0.00173	CcSEcCtD
Risedronate—Headache—Quinidine—malaria	0.000809	0.00172	CcSEcCtD
Risedronate—Headache—Quinine—malaria	0.000809	0.00172	CcSEcCtD
Risedronate—Nausea—Dapsone—malaria	0.000809	0.00171	CcSEcCtD
Risedronate—Diarrhoea—Quinidine barbiturate—malaria	0.000798	0.00169	CcSEcCtD
Risedronate—Diarrhoea—Pentoxifylline—malaria	0.000796	0.00169	CcSEcCtD
Risedronate—Nausea—Clindamycin—malaria	0.000782	0.00166	CcSEcCtD
Risedronate—Dizziness—Quinidine barbiturate—malaria	0.000771	0.00163	CcSEcCtD
Risedronate—Dizziness—Pentoxifylline—malaria	0.00077	0.00163	CcSEcCtD
Risedronate—Nausea—Quinine—malaria	0.000767	0.00163	CcSEcCtD
Risedronate—Nausea—Quinidine—malaria	0.000767	0.00163	CcSEcCtD
Risedronate—Vomiting—Quinidine barbiturate—malaria	0.000741	0.00157	CcSEcCtD
Risedronate—Vomiting—Pentoxifylline—malaria	0.00074	0.00157	CcSEcCtD
Risedronate—Rash—Quinidine barbiturate—malaria	0.000735	0.00156	CcSEcCtD
Risedronate—Dermatitis—Quinidine barbiturate—malaria	0.000734	0.00156	CcSEcCtD
Risedronate—Rash—Pentoxifylline—malaria	0.000734	0.00156	CcSEcCtD
Risedronate—Dermatitis—Pentoxifylline—malaria	0.000733	0.00155	CcSEcCtD
Risedronate—Headache—Quinidine barbiturate—malaria	0.00073	0.00155	CcSEcCtD
Risedronate—Headache—Pentoxifylline—malaria	0.000729	0.00155	CcSEcCtD
Risedronate—Nausea—Quinidine barbiturate—malaria	0.000692	0.00147	CcSEcCtD
Risedronate—Nausea—Pentoxifylline—malaria	0.000691	0.00147	CcSEcCtD
Risedronate—FDPS—SREBP signalling—SCARB1—malaria	0.000114	0.0917	CbGpPWpGaD
Risedronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000106	0.0857	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—CRP—malaria	4.32e-05	0.0349	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—DECR1—malaria	4.18e-05	0.0337	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—KDR—malaria	4.14e-05	0.0334	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	4.1e-05	0.0331	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—HBB—malaria	4.03e-05	0.0325	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	3.84e-05	0.0309	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	3.66e-05	0.0296	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	3.56e-05	0.0288	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	2.42e-05	0.0195	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	2.37e-05	0.0191	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	2.36e-05	0.0191	CbGpPWpGaD
Risedronate—FDPS—Metabolism—DHODH—malaria	2.33e-05	0.0188	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	2.31e-05	0.0186	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.29e-05	0.0185	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	2.28e-05	0.0184	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	2.24e-05	0.0181	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	2.15e-05	0.0174	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.1e-05	0.017	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC4A1—malaria	1.98e-05	0.016	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—malaria	1.96e-05	0.0158	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—FCGR2A—malaria	1.93e-05	0.0156	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	1.91e-05	0.0154	CbGpPWpGaD
Risedronate—FDPS—Metabolism—DECR1—malaria	1.86e-05	0.015	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HBB—malaria	1.68e-05	0.0136	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—malaria	1.58e-05	0.0127	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PKLR—malaria	1.5e-05	0.0121	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	1.39e-05	0.0112	CbGpPWpGaD
Risedronate—FDPS—Metabolism—G6PD—malaria	1.34e-05	0.0108	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CD36—malaria	1.32e-05	0.0106	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	1.31e-05	0.0106	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—malaria	1.27e-05	0.0102	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	1.24e-05	0.00999	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	1.17e-05	0.0094	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL4—malaria	1.16e-05	0.00936	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HPGDS—malaria	1.02e-05	0.00822	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	1e-05	0.00807	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	9.64e-06	0.00778	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TLR4—malaria	9.61e-06	0.00775	CbGpPWpGaD
Risedronate—FDPS—Metabolism—DHFR—malaria	9.46e-06	0.00763	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SCARB1—malaria	9.36e-06	0.00755	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—malaria	9.21e-06	0.00743	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—malaria	9.14e-06	0.00738	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	9.02e-06	0.00728	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CD4—malaria	8.89e-06	0.00717	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IFNG—malaria	8.87e-06	0.00715	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—malaria	7.91e-06	0.00638	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	7.27e-06	0.00587	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—malaria	7.01e-06	0.00566	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—malaria	6.25e-06	0.00505	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—malaria	6.23e-06	0.00503	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CD36—malaria	5.87e-06	0.00474	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—malaria	5.74e-06	0.00463	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DHODH—malaria	5.57e-06	0.0045	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.48e-06	0.00442	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.03e-06	0.00406	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC4A1—malaria	4.74e-06	0.00382	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—malaria	4.63e-06	0.00374	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—malaria	4.54e-06	0.00366	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DECR1—malaria	4.46e-06	0.0036	CbGpPWpGaD
Risedronate—PTGS2—Disease—PKLR—malaria	4.29e-06	0.00346	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HBB—malaria	4.03e-06	0.00325	CbGpPWpGaD
Risedronate—PTGS2—Disease—G6PD—malaria	3.82e-06	0.00308	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—malaria	3.66e-06	0.00295	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PKLR—malaria	3.59e-06	0.0029	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—G6PD—malaria	3.2e-06	0.00258	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	3.16e-06	0.00255	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	3.09e-06	0.00249	CbGpPWpGaD
Risedronate—PTGS2—Disease—DHFR—malaria	2.7e-06	0.00218	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPGDS—malaria	2.44e-06	0.00197	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DHFR—malaria	2.27e-06	0.00183	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SCARB1—malaria	2.24e-06	0.00181	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD36—malaria	1.41e-06	0.00113	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—malaria	1.38e-06	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—malaria	1.02e-06	0.000825	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—malaria	5.53e-07	0.000446	CbGpPWpGaD
